Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IO vs IV Vancomycin in Total Shoulder Arthroplasty
NCT05831774Phase 4Active, not recruiting
- Sponsor
- Houston Methodist Research Institute
- Start
- Jun 2023
- Primary completion
- Jul 2024
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vancomycin in surgical site infection (SSI), sponsored by Houston Methodist Research Institute. Started Jun 2023; status: active, not recruiting.
02
Drugs
vancomycin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT05831774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05831774.